SCHEDULE: Vanguard Group Amends Astera Labs Ownership to Zero
Beneficial Ownership Report Amendment
The Vanguard Group filed an amended Schedule 13G, reporting 0% beneficial ownership of Astera Labs Inc. Common Stock following an internal realignment.
Summary
- The Vanguard Group filed an Amendment No. 2 to Schedule 13G regarding its beneficial ownership of Astera Labs Inc. Common Stock.
- The filing indicates that The Vanguard Group now beneficially owns 0.00 shares, representing 0% of the class of securities.
- This change is a result of an internal realignment within The Vanguard Group, Inc. that occurred on January 12, 2026.
- Following the realignment, certain subsidiaries or business divisions of Vanguard will report beneficial ownership separately, and The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over these securities.
- The filing was made pursuant to Rule 13d-1(b) and certifies that the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral. It is a procedural update reflecting an internal organizational change at The Vanguard Group, not a reflection of Astera Labs' performance or a strategic investment decision regarding the issuer.
Positives
- NA
Negatives
- NA
Risks
- NA
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding Astera Labs Inc. or its future performance.
Management Comments
- The Vanguard Group, Inc. went through an internal realignment on January 12, 2026, leading certain subsidiaries to report beneficial ownership separately.
- The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.
Industry Context
StockSavvy.ai notes that Schedule 13G filings are typically made by passive institutional investors who own more than 5% of a company's stock. An amendment reporting 0% ownership due to an internal realignment, as seen with The Vanguard Group, is a procedural update reflecting changes in the reporting entity's internal structure rather than a strategic divestment based on the issuer's performance. This type of filing is common for large asset managers with complex organizational structures.
Comparison to Industry Standards
- NA
Legal Proceedings
- NA
Related Party Transactions
- NA
Stakeholder Impact
- This filing has minimal direct impact on Astera Labs' shareholders, employees, customers, suppliers, or creditors, as it primarily reflects a change in how The Vanguard Group reports its holdings rather than a change in underlying investment strategy or a significant divestment based on the issuer's fundamentals.
Next Steps
- NA
Key Dates
| Date | Description |
|---|---|
| 1998-01-12 | SEC Release No. 34-39538, referenced for rules regarding disaggregated reporting. |
| 2026-01-12 | Date of internal realignment at The Vanguard Group, Inc., leading to changes in beneficial ownership reporting. |
| 2026-03-13 | Date of event which required the filing of this Schedule 13G Amendment. |
| 2026-03-26 | Signature date of the Schedule 13G Amendment by The Vanguard Group. |
Keywords
Schedule 13G, Vanguard Group, Astera Labs Inc, Beneficial Ownership, Common Stock, Internal Realignment, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.